Sajid, M., R. Zhao, A. Pathak, S. S. Smyth, and G. A. Stouffer. ␣ v3-Integrin antagonists inhibit thrombin-induced proliferation and focal adhesion formation in smooth muscle cells. Am J Physiol Cell Physiol 285: C1330-C1338, 2003. First published July 23, 2003 10.1152 10. /ajpcell.00475.2002tegrin antagonists reduced neointimal formation following vascular injury in eight different animal models. Because ␣-thrombin contributes to neointimal formation, we examined the hypothesis that ␣ v3-integrins influence ␣-thrombin-induced signaling. Cultured rat aortic smooth muscle cells (RASMC) expressed ␣ v3-integrins as demonstrated by immunofluorescence microscopy and fluorescence-activated cell sorting analysis. Proliferative responses to ␣-thrombin were partially inhibited by anti- 3-integrin monoclonal antibody F11 and by cyclic RGD peptides. Immunofluorescence microscopy showed that ␣-thrombin stimulated a rapid increase in the formation of focal adhesions as identified by vinculin staining and that this effect was partially inhibited by ␣ v3 antagonists. 3-Integrin staining was diffuse in quiescent RASMC and did not concentrate at sites of focal adhesions following thrombin treatment. ␣-Thrombin elicited a time-dependent increase in activation of c-Jun NH 2-terminal kinase-1 (JNK1) and in tyrosine phosphorylation of focal adhesion kinase (FAK). ␣ v3-Integrin antagonists partially inhibited increases in JNK1 activity but had no effect on FAK phosphorylation. In SMC isolated from  3-integrin-deficient mice, focal adhesion formation was impaired in response to thrombin but not sphingosine-1-phosphate, a potent activator of Rho. In summary, ␣ v3-integrins play an important role in ␣-thrombin-induced proliferation and focal adhesion formation in RASMC.receptors; vitronectin; integrins; focal adhesions PERCUTANEOUS CORONARY INTERVENTION (PCI) involves application of a controlled injury to a coronary artery to relieve focal obstruction. The injury stimulates a healing response, which, when overexuberant, leads to renarrowing of the artery in a process labeled "restenosis." Animal models have implicated ␣ v  3 -integrins in playing an important role in vascular healing responses. Studies in baboons, rats, rabbits, and pigs have shown that balloon angioplasty is a stimulus for  3 -integrin expression by vascular smooth muscle cells (SMC) (6,21,23) and that treatment with ␣ v  3 antagonists reduces (neo)intima formation after vascular injury (reviewed in Ref. 19).␣ v  3 -Integrins influence responses of cultured SMC to many extracellular agonists that may be important in healing responses in injured blood vessels. In addition to inhibiting responses to agents that directly bind ␣ v  3 , such as thrombospondin and osteopontin (23,24,27), ␣ v  3 antagonists also regulate SMC responses to platelet-derived growth factor (3, 4), epidermal growth factor (10), insulin-like growth factor-I (9), transforming growth factor- (18), and ␣-thrombin (24). ␣-Thrombin is of particular interest because it is concentrated at ...